跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
THE-630
首页
药物
THE-630
Investigational
Small Molecule
THE-630
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
HYBRID PROTEIN FOR THE IDENTIFICATION OF NEDDYLATED SUBSTRATES
EP 3259283 B1
申请人: SANTONICO ELENA
优先权: 2015
EP
US
WO
4 件公开
4-cyanocoumarin derivatives and uses thereof
US 7375225 B2
申请人: HAYASHIBARA BIOCHEM LAB
优先权: 2001
US
4 件公开
COMBINATION THERAPY COMPRISING KIT INHIBITORS FOR USE IN THE TREATMENT OF CANCER
EP 4719421 A1
申请人: IDRX INC
优先权: 2023
CN
EP
WO
3 件公开
[METHODS AND APPARATUSES FOR ISOLATING AND PREPARING STEM CELLS]
US 2012101479 A1
申请人: PASPALIARIS BILL
优先权: 2009
US
3 件公开
Pharmaceutical Composition in the Form of Granules for the Treatment of Metabolic Disorders in Children
US 2016136103 A1
申请人: ASSIST PUBL HOPITAUX DE PARIS
优先权: 2013
EP
US
2 件公开
Cosmetic composition comprising an extract of Caesalpinia spinosa, an extract of Kappaphycus alvarezii, and a Theobroma cacao L bean hydrolysate
US 12138337 B2
申请人: LVMH RECH
优先权: 2017
CN
US
2 件公开
DIET PREPARATION FOR THE NUTRITION OF CANCER PATIENTS WITH A RESTRICTED CALORIE INTAKE
US 20240000125 A1
申请人: FONDAZIONE IRCCS ISTITUTO NAZ DEI TUMORI
优先权: 2020
US
WO
2 件公开
Chromene compound
US 7048876 B2
申请人: TOKUYAMA CORP
优先权: 2002
US
2 件公开
Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 1521, 6662, 13913, 12405 or 5014
US 2006078947 A1
申请人: MILLENNIUM PHARM INC
优先权: 2004
US
2 件公开
Optical film and phase difference plate, and liquid crystal compound
US 8293146 B2
申请人: UEHIRA SHIGEKI
优先权: 2006
US
2 件公开
第 1 / 9 页
上一页
下一页
药物
反馈